Source: Annual Congress 2006 - Epidemiology and treatment of tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
W. V. Senaratne, M. J. Pinidiyapathirage, E. Perera, A. R. Wickremasinghe (Welisara, Ragama, Sri Lanka). Anti tuberculosis drug induced hepatitis in Sri Lankan patients. Eur Respir J 2006; 28: Suppl. 50, 1743

Member's Comments

No comment yet.

Related content which might interest you: An analysis of mortality among patients with tuberculosis (TB) in Sri Lanka Source: Annual Congress 2011 - Tuberculosis epidemiology and public health Year: 2011 High prevalence of hepatitis C among patients with drug-resistant tuberculosis and its impact on the treatment outcome in Azerbaijan prisons Source: International Congress 2015 – Screening strategies in TB Year: 2015 HIV seroprevalence among tuberculosis patients in Tripoli Libya Source: Eur Respir J 2004; 24: Suppl. 48, 197s Year: 2004 A study on prevalence of latent tuberculosis in prison inmates of a single outdoor prison in central  Sri Lanka Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations Year: 2020 Prevalence of latent tuberculosis among refugee children in Malaysia Source: ERJ Open Res, 6 (1) 00254-2019; 10.1183/23120541.00254-2019 Year: 2020 Prevalence of hepatitis C virus in patients with tuberculosis and its impact in the incidence of anti-tuberculosis drugs induced hepatotoxicity Source: International Congress 2015 – Screening strategies in TB Year: 2015 Influence of viral hepatitis and anti-TB drugs on hepatocyte disfunction in patients with MDR/XDR tuberculosis Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis Year: 2021 Treatment of latent tuberculosis in immigrants from Somalia: Case-monitoring and adherence Source: Annual Congress 2010 - Tuberculosis in special populations Year: 2010 Risk factors of drug -induced hepatitis among patients with TB/HIV co-infection Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities Year: 2010 Impact of HIV infection on drug resistance pattern of anti-tuberculosis drugs in PTB cases in Eastern Uttar Pradesh (India) Source: Eur Respir J 2004; 24: Suppl. 48, 438s Year: 2004 Clinico-radiological profile of tuberculosis in HIV seropositive patients of western Rajasthan Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis Year: 2008 Particularities of tuberculosis at children hospitalized with HIV co-infection Source: Annual Congress 2009 - Tuberculosis at different age groups Year: 2009 Safety of bedaquiline for treatment of MDR/XDR tuberculosis in HIV co-infected patients Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019 Should patients with active tuberculosis be routinely screened for chronic viral hepatitis? Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 Anti tubercular chemoprophylaxis regimens in HIV seropositives with latent tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 566s Year: 2002 Tuberculosis for HIV infected patients in Latvia Source: Eur Respir J 2001; 18: Suppl. 33, 314s Year: 2001 HIV co-infection excludes many drug-resistant tuberculosis patients from clinical trials with novel antituberculosis drugs Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Prevalence of urban vs rural HIV infection in patients of pulmonary tuberculosis: An Indian scenario Source: Annual Congress 2010 - Clinical tuberculosis Year: 2010 Multidrug-resistance tuberculosis and HIV-infected patients, the effectiveness of the treatment in Ukraine Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010 Recurrent tuberculosis among HIV infected persons in Singapore Source: International Congress 2017 – Human susceptibility to tuberculosis Year: 2017